Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.
Sami M, Worker A, Colizzi M, Annibale L, Das D, Kelbrick M, Eranti S, Collier T, Onyejiaka C, O'Neill A, Lythgoe D, McGuire P, Williams SCR, Kempton MJ, Bhattacharyya S; Collaborators. Sami M, et al. Among authors: eranti s. Transl Psychiatry. 2020 Apr 21;10(1):111. doi: 10.1038/s41398-020-0790-1. Transl Psychiatry. 2020. PMID: 32317625 Free PMC article.
The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M. McLoughlin DM, et al. Among authors: eranti s. Health Technol Assess. 2007 Jul;11(24):1-54. doi: 10.3310/hta11240. Health Technol Assess. 2007. PMID: 17580003 Free article. Clinical Trial.
Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
Knapp M, Romeo R, Mogg A, Eranti S, Pluck G, Purvis R, Brown RG, Howard R, Philpot M, Rothwell J, Edwards D, McLoughlin DM. Knapp M, et al. Among authors: eranti s. J Affect Disord. 2008 Aug;109(3):273-85. doi: 10.1016/j.jad.2008.01.001. Epub 2008 Feb 11. J Affect Disord. 2008. PMID: 18262655 Clinical Trial.
20 results